<DOC>
	<DOCNO>NCT02156440</DOCNO>
	<brief_summary>Osteoarthritis ( OA ) affect approximately 10 % people older 60 year , compromise quality life 21 million North Americans . Studies use complimentary alternative medicine report OA patient US among high user CAM . Previous study unique natural mineral product SierraSil® demonstrate improvement joint health function subject mild moderate OA knee . Extracts Sierrasil® report reduce cartilage degradation response IL-8 nitric oxide production suggest ability suppress IL-8 mediate event human cartilage . The primary objective ass efficacy SeirraSil Joint Formula versus placebo symptom osteoarthritis assessed WOMAC™ Osteoarthritis Index Pain subscale subject osteoarthritis knee .</brief_summary>
	<brief_title>Cross-over Study Efficacy Safety SierraSil Joint Formula 14 Osteoarthritis Knee</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<criteria>Male female 1865 year age If female , subject child bear potential . Defined female hysterectomy oophorectomy , bilateral tubal ligation postmenopausal ( natural surgically &gt; 1 year since last menstruation ) . OR Female subject childbearing potential must agree use medically approve method birth control negative urine pregnancy test result . Acceptable method birth control include : Hormonal contraceptive include oral contraceptive , hormone birth control patch ( Ortho Evra ) , vaginal contraceptive ring ( NuvaRing ) , injectable contraceptive ( DepoProvera , Lunelle ) , hormone implant ( Norplant System ) Intrauterine device Vasectomy partner ( show successful per appropriate followup ) Abstinence Primary secondary , unilateral bilateral osteoarthritis knee ( American College Rheumatology Clinical Criteria Classification ) Knee pain least 3 follow : Age &gt; 50 year Stiffness &lt; 30 minute Crepitus Bony Tenderness Bony enlargement No palpable warmth Self report difficulty perform least one follow activity knee pain : lifting carry grocery walk onequarter mile get chair go stairs mobility selfcare activity Able walk unassisted ( may use walk stick , crutch , knee brace ) Availability duration study period ( 14 week ) Subject use therapy OA , exercise , heat/cold therapy , joint protection physiotherapy/occupational therapy agree continue therapy normal avoid change frequency intensity record therapy study diary Subject agree start new therapy OA course study Has give voluntary , write , inform consent participate study Women pregnant , breastfeeding , plan become pregnant course trial Subject diagnosis rheumatoid arthritis , fibromyalgia , spinal disorder musculoskeletal disease Subject recommend knee surgery Subject hemosiderosis hemochromatosis Subject kidney liver disease , blood disorder , active cancer and/or HIV infection Subject significant medical history current metabolic disorder , thyroid disease , immune disorder and/or cardiovascular disease review Qualified Investigator ( QI ) . Subjects deem QI possible risk permit study . Use illicit drug history drug alcohol abuse past 5 year ( currently 2 standard alcoholic drink per day ) Planned surgery course trial Use intraarticular , oral parenteral corticosteroid , injectable prescription medication ( e.g. , Synvisc ) within 2 month prior randomization trial Requires use prescription drug control pain ( provide rescue medication ) Use oral topical prescription counter medication natural health product pain relief 48 hour prior randomization trial ( provide rescue medication ) Use iron supplementation trial ( i.e . provide multivitamin , prescription medication , mineral preparation contain iron ) Use antacid contain aluminum aluminum contain medication supplement trial Clinically significant abnormal laboratory result screen Abnormal serum ferritin level ≥200 µg/L Abnormal serum aluminum level &gt; 16 µg/L eGFR &lt; 60 abnormal liver function test Allergy sensitivity test product ingredient Individuals cognitively impair and/or unable give inform consent Any condition Investigator 's opinion may adversely affect subject 's ability complete study measure may pose significant risk subject</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Ostearthritis</keyword>
	<keyword>Knee</keyword>
	<keyword>SierraSil</keyword>
</DOC>